AzTrials
AzTrials

MicrocirculationSpeckleShakeNCT01169974

Use of Laser Speckle to Study Post Occlusive Reactive Hyperhemia in Healthy Subjects

An observational study of Microcirculation, run by University Hospital, Angers at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators aim to test the hypothesis that Laser speckle contrast imaging allows for the measurement of cutaneous blood flow following various durations of tourniquet ischemia. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Microcirculation
What is being tested?
tourniquet ischemia
How many people
41 participants
Where
1 siteFrance
Study dates
1 Feb 2011to 4 Dec 2012
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: healthy volunteers

Who may be able to join

  • Healthy volunteers
  • Affiliation to the French health system

Who cannot join

  • Any disease or chronic treatment

Trial locations and contacts

1 site in 1 country.

France1 site
  • University hospital

    Angers

Other trials in France

About this study

Official title: Evaluation Chez Des Sujets Volontaires Sains de l'ischémie-reperfusion cutanée

The investigators aim to test the hypothesis that Laser speckle contrast imaging allows for the measurement of cutaneous blood flow following various durations of tourniquet ischemia.

Read the detailed description

Ischemia and post occlusive reactive hyperemia in the skin is tested in healthy normal subjects for tourniquet ischemias of 1, 2 \& 3 minutes at rest.

Being tested
tourniquet ischemia
Keywords
Microcirculation, laser flowmetry, Skin, Physiology

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • tourniquet ischemiaOther

    Also called Laser doppler flowmetry, Transcutaneous oxygen pressure, Near infra-red spectrometry, Plethysmography

    Recording of cutaneous blood flow on the forearm at rest before and following tourniquet ischemias of 1 , 2 \& 3 minutes

Study groups in NCT01169974
Study groupRoleWhat they receive
healthy volunteersNot described
Receives: Other: tourniquet ischemia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Laser speckle

    Peak value of laser speckle signal

    Measured: with 2 minutes of ischemia

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jul 2010 (estimated)
  2. Study start1 Feb 2011
  3. Primary completionSep 2012
  4. Study completion4 Dec 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
41 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01169974
Sponsor's protocol ID
CHU P 2010-18
Acronym
SpeckleShake
Status last verified
Oct 2017
First submitted
23 Jul 2010
Last updated
1 Nov 2017
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Microcirculation, run by University Hospital, Angers at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Nov 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Laser speckle (time frame: with 2 minutes of ischemia). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Nov 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in